Fulcrum Therapeutics (FULC) Tmuɣli n wazal
Fulcrum Therapeutics Inc
Ṛṛbem n lḥedd$3.74Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-1.32%
Asnulfu n AI: FULC
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Fulcrum Therapeutics is a biopharmaceutical company focused on developing therapies for genetic diseases. The company has developed product candidates designed to modulate gene expression and potentially address the underlying causes of these conditions.
